Table 1 Baseline demographic and clinical characteristics in training and external validation sets
Clinical characteristics | Training set (n = 1103) | External validation set 1 (n = 513) | External validation set 2 (n = 404) | p-value |
|---|---|---|---|---|
Sex, n(%) | 0.407a | |||
Male | 783 (71.0%) | 371 (72.3%) | 276 (68.3%) | |
Female | 320 (29.0%) | 142 (27.7%) | 128 (31.7%) | |
Age (years, Mean ± SD) | 60.08 ± 13.36 | 59.91 ± 13.69 | 60.75 ± 13.98 | 0.611b |
Hematoma expansion, n(%) | 0.621a | |||
Yes | 218 (19.8%) | 112 (21.8%) | 81 (20.0%) | |
No | 885 (80.2%) | 401 (78.2%) | 323(80.0%) | |
Baseline volume [mL, Median (IQR)] | 20.36 (21.95) | 19.75 (21.65) | 20.06 (21.53) | 0.820c |
Follow-up volume [mL, Median (IQR)] | 22.70 (26.15) | 22.59 (26.95) | 22.84 (27.15) | 0.800c |